News
A study presents MCLA-158, the first drug candidate targeting cancer stem cells from solid tumors
An international consortium led by IRB Barcelona and the biotech company Merus, with the participation of IDIBELL and the Catalan Institute of Oncology, presents the preclinical data leading to the discovery of MCLA-158 and its action mechanism on cancer stem cells.
Two IDIBELL members receive 2021 Biologist Day awards
Two of the 2021 Biologist Day awards, celebrated by the College of Biologists of Catalonia, are given to two members of IDIBELL: Dr. Milagros González Garrigues and Dr. Núria Sala-Serra.
Success at the Presentation Conference of the Bellvitge Campus Scientific and Technical Services
On Thursday afternoon, April 21, the Presentation Conference of the Bellvitge Campus Scientific and Technical Services for Clinical Research took place with the aim of raising awareness of the research support services that IDIBELL and UB offer to researchers in the Bellvitge Campus.
Study of skin biopsies offers potential as new diagnostic marker for ALS
Researchers from IDIBELL, HUB, UAB and Hospital del Mar have identified the presence of an ALS biomarker outside the nucleus of skin cells of patients. The discovery can be very useful for cases in which diagnosis is difficult, or in those with a family history of ALS, and even for early diagnosis.
IDIBELL becomes a member of the Pessics de Ciència Scientific Committee
IDIBELL, together with other scientific institutions in Catalonia, is already part of the Scientific Committee for Pessics de Ciència.
The Department of Research and Universities produces a video on IDIBELL’s biomedical research to promote scientific vocations among young people
The second edition of the RECERCLIPS collection explains genetics research at IDIBELL and is presented by the youtuber Juliana Canet.
Research is written in feminine: IDIBELL women and their career
The glass ceiling, family reconciliation and gender stereotypes are barriers that have had to be overcome, but they have not been an impediment to becoming the leading scientists today.
Researchers identify the biological basis responsible for developing breast cancer in patients with mutations in BRCA1
A study by IDIBELL and ICO, published in the journal Nature Communications, indicates that overexpression of the HMMR gene in women with BRCA1 mutations alters key cellular processes and accelerates the development of breast cancer.
Researchers identify a gene that causes a new neurological and bone syndrome
An international team led by IDIBELL and Necker Hospital in Paris has identified mutations in the SLC35B2 gene as responsible for a syndrome that, although very rare and hitherto unknown, could be affecting hundreds of people around the world who would still remain undiagnosed. Symptoms of this disorder include neurodevelopmental delay, motor dysfunctions, and deformity […]